sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
caus
agent
sar
identifi
new
type
coronaviru
name
sarsassoci
coronaviru
sarscov
shortli
st
report
case
guangdong
southern
china
late
outbreak
sar
spread
vietnam
hong
kong
singapor
canada
area
includ
taiwan
june
probk
r
g
e
r
abl
sar
case
includ
death
report
world
health
organ
countri
region
worldwid
st
case
sar
taiwan
male
return
busi
trip
guangdong
diagnos
report
earli
march
subsequ
larg
outbreak
took
place
late
april
partli
due
unrecogn
sar
index
patient
made
multipl
visit
differ
hospit
expos
mani
patient
visitor
health
care
worker
result
probabl
case
death
taiwan
end
june
genom
sarscov
positivesens
singlestrand
rna
sequenc
distantli
relat
known
coronavirus
infect
human
anim
like
known
coronavirus
sarscov
envelop
viru
contain
three
envelop
protein
name
membran
envelop
e
spike
protein
nucleocapsid
n
protein
togeth
viral
rna
genom
presum
tbrm
helic
core
locat
insid
viral
envelop
base
structur
known
coronavirus
protein
transmembran
glycoprotein
abund
protein
viru
particl
e
protein
present
minut
amount
viral
envelop
coronavirus
protein
shown
bind
cellular
receptor
host
cell
surfac
gener
immun
respons
protein
believ
prevent
viral
attach
entri
host
ceil
begin
sar
outbreak
case
definit
sar
mere
base
clinic
histori
symptom
howev
confirm
sarscov
caus
agent
laboratori
method
includ
viral
isol
nucleic
acid
test
serolog
test
quickli
develop
accept
one
categori
sar
diagnosi
even
though
rtpcr
realtim
pcr
current
sensit
techniqu
detect
sarscov
posit
rate
probabl
sar
case
around
accord
data
center
diseas
control
taiwan
cdctaiwan
like
specimen
might
obtain
optim
time
point
cours
sarscov
infect
specimen
might
taken
improperli
especi
nasopharyng
aspir
throat
swab
thu
suggest
multipl
repeat
collect
nasopharyng
throat
fecal
sampl
taken
order
increas
posit
rate
determin
rtpcr
addit
nucleic
acid
test
serodiagnosi
sar
also
import
given
sar
new
diseas
human
antibodi
sarscov
detect
peopl
expos
viru
antibodi
occur
sera
would
use
index
sar
infect
report
igg
sarscov
detect
convalesc
sera
use
sarscovinfect
vero
cell
antigen
indirect
immunofluoresc
assay
ifa
reduc
risk
infect
bacteri
express
recombin
sarscov
protein
instead
whole
viru
use
antigen
western
blot
wb
assay
recombin
protein
includ
n
e
variou
truncat
form
protein
test
see
whether
react
sera
probabl
sar
patient
collect
acut
convalesc
stage
ill
humor
immun
display
differ
isotyp
antibodi
includ
iga
igg
igm
infect
thu
evalu
whether
antibodi
could
use
diagnost
indic
sar
infect
result
wb
analys
summar
compar
ifa
rtpcr
overal
result
recombin
proteinbas
wb
wholevirusbas
ifa
show
high
correl
code
region
sarscov
protein
n
e
fragment
protein
amplifi
cycl
pcr
use
reversetranscrib
rna
extract
urbani
strain
sarscov
genbank
access
urbani
strain
nucteotid
length
kindli
provid
center
diseas
control
prevent
cdcu
atlanta
ga
usa
sequenc
primer
use
pcr
list
tabl
amplicon
carri
either
bamhisal
bamhihindiii
restrict
site
size
nucleotid
sequenc
n
bp
e
bp
amplifi
product
purifi
gel
clone
express
vector
qiagen
studio
citi
calif
usa
result
construct
transform
escherichia
coli
cell
invitrogen
carlsbad
calif
usa
sequenc
insert
verifi
use
abi
dna
analyz
appli
biosystem
tokyo
japan
protein
express
e
coii
coloni
e
coli
cell
separ
inocul
lb
broth
presenc
hindiii
f
denot
tbrward
primer
b
r
denot
revers
primer
centrifug
rpm
rain
pellet
resuspend
eppendorf
vial
contain
sarcosin
mm
buffer
ph
vortex
room
temperatur
h
lysat
appear
clear
recentrifug
rpm
min
supernat
collect
bd
talon
tm
metal
affin
resin
bd
bioscienc
san
jose
calif
usa
ad
vial
mildli
agit
overnight
resin
centrifug
wash
twice
mm
buffer
contain
protein
examin
sdspage
protein
either
stain
coomassi
blue
transfer
polyvinyliden
difluorid
membran
pvdf
immobilon
p
pore
size
gin
millipor
bedford
mass
usa
determin
recombin
protein
elimin
bacteli
contamin
present
inclus
bodi
recombin
protein
elut
mm
imidazol
solut
accord
manufactur
instruct
accord
criteria
person
present
novemb
histori
high
fever
c
cough
breath
difficulti
resid
travel
area
recent
local
transmiss
sar
day
prior
onset
symptom
classifi
suspect
case
suspect
case
radiograph
evid
infiltr
consist
pneumonia
respiratori
distress
syndrom
chest
xray
consid
probabl
case
studi
human
serum
sampl
patient
fulfil
criteria
probabl
sar
case
select
hospit
patient
northern
taiwan
male
femal
case
pair
sera
singl
serum
collect
either
acut
stage
convalesc
stage
ill
serum
sampl
analyz
sarscov
rtpcr
among
posit
neg
primer
use
rtpcr
synthes
accord
cdcu
recommend
handl
specimen
collect
take
aliquot
dilut
specimen
practic
nucleic
acid
extract
rtpcr
assay
perform
biosafeti
level
laboratori
laboratori
worker
requir
wear
protect
equip
includ
dispos
glove
laboratori
coat
mask
hrpconjug
goat
antihuman
immunoglobulin
iga
c
chain
igg
chain
igm
g
chain
purchas
savyon
diagnost
ashdod
israel
product
purifi
affin
column
veto
cell
grown
mem
contain
fetal
bovin
serum
densiti
cell
infect
sarscov
cytopath
effect
appear
cell
wash
trypsin
spot
onto
slide
slide
place
close
heat
contain
complet
dri
slide
fix
aceton
rain
ten
microlit
dilut
serum
start
place
onto
well
slide
incub
rain
wash
twice
pb
rain
gl
specif
antihuman
gamma
globulin
label
fitc
zyme
laboratori
south
san
francisco
calif
usa
ad
well
incub
rain
wash
twice
pb
slide
observ
fluoresc
microscop
cultur
viru
prepar
viral
antigen
ifa
conduct
laboratori
fix
aceton
ifa
slide
examin
laboratori
equal
amount
purifi
recombin
protein
mix
subject
sdspage
transfer
pvdf
membran
membran
block
skim
milk
difco
spark
md
usa
pb
h
room
temperatur
slice
strip
x
cm
therefor
load
strip
theoret
equal
serum
sampl
dilut
skim
milk
two
millilit
dilut
serum
ad
strip
incub
overnight
follow
day
strip
wash
pb
contain
tween
three
time
min
incub
room
temperatur
h
ml
goat
antihuman
igg
iga
igm
hrp
conjug
savyon
diagnost
separ
wash
describ
strip
incub
ecl
solut
perkinelm
life
scienc
boston
mass
usa
rain
strip
dri
expos
xray
film
visual
reaction
sensit
number
true
posit
number
true
posit
number
fals
neg
specif
number
true
neg
number
true
neg
number
fals
posit
calcul
previous
describ
antibodi
respons
differ
immunoglobulin
class
sarscov
recombin
protein
plot
accord
optic
densiti
wb
scan
quantifi
use
totallab
softwar
nonlinear
dynam
newcastl
upon
tyne
uk
valu
band
normal
wkh
control
serum
result
subject
sigma
plot
curv
plot
pairtopair
ttest
statist
analys
p
consid
signific
encod
region
fulllength
e
n
protein
truncat
form
protein
sarscov
mark
figur
easi
handl
amino
acid
long
open
read
frame
protein
split
seven
consecut
truncat
form
polypeptid
design
induct
iptg
protein
synthes
present
inclus
bodi
resolv
buffer
contain
sarcosin
purifi
metal
affin
resin
sampl
bacteri
express
sarscov
n
e
protein
analyz
shown
figur
molecular
mass
n
e
kd
respect
expect
howev
appar
molecular
mass
recombin
protein
gel
kd
larger
calcul
size
approxim
kd
possibl
due
high
content
hydrophob
amino
acid
residu
protein
recombin
protein
poorli
express
e
coli
therefor
use
studi
data
shown
w
recombin
protein
pool
test
see
whether
react
antibodi
serum
sampl
probabl
sar
patient
wb
analysi
among
posit
result
wb
rtpcr
analys
also
repres
variou
stage
ill
select
present
figur
serum
sampl
patient
collect
day
onset
ill
label
exampl
indic
femal
patient
day
serum
two
serum
sampl
healthi
peopl
use
neg
control
sarscovspecif
antibodi
fig
lane
shown
figur
n
protein
could
recogn
iga
igg
igm
fig
lane
fig
lane
fig
lane
howev
protein
recogn
iga
igg
bare
recogn
igm
fig
lane
fig
lane
fig
lane
two
recombin
protein
e
recogn
iga
igg
igm
serum
sar
patient
protein
band
arrowhead
might
repres
degrad
product
protein
contamin
unknown
protein
copurifi
recombin
protein
sinc
specif
igm
found
weakli
react
antigen
sinc
posit
case
igm
includ
iga
igg
igm
analyz
follow
studi
taken
togeth
result
demonstr
recombin
n
protein
could
use
diagnost
marker
sarscov
infect
order
elucid
clearli
antibodi
respons
variou
antigen
sarscov
line
diagram
drawn
accord
wb
result
fig
coli
protein
purifi
affin
resin
stain
coomassi
blue
sdspage
polyacrylamid
gel
lane
show
individu
purifi
protein
lane
show
six
pool
protein
use
wb
mlalysi
healthi
volunt
howev
must
emphas
antibodi
respons
profil
repres
pool
data
select
probabl
sar
patient
kinet
chang
individu
shown
figur
n
protein
possess
major
antigen
variou
antibodi
tga
igg
igm
notic
antibodi
respons
iga
n
protein
initi
earli
day
ill
onset
sevenfold
increas
progress
increas
within
month
fig
increas
multipl
antibodi
n
protein
significantli
higher
protein
protein
accord
pair
ttest
p
p
respect
respons
igm
igg
n
protein
similar
iga
howev
appear
day
respect
onset
ill
protein
could
detect
iga
igg
antibodi
respons
protein
much
lower
n
protein
fig
interestingli
patient
iga
antibodi
respons
spike
protein
earli
stage
day
patient
similar
respons
convalesc
stage
day
ill
onset
g
express
profil
antibodi
respons
n
protein
higher
protein
p
p
respect
pair
test
b
igg
express
profil
antibodi
respons
n
protein
higher
protein
p
pair
test
c
igm
express
profil
antibodi
respons
n
protein
significantli
differ
protein
p
pair
ttest
evalu
sensit
specif
wb
assay
use
recombin
protein
studi
compar
data
wb
result
wholevirusbas
ifa
tabl
show
sensit
specif
tabl
show
result
rtpcr
wb
acut
convalesc
stage
ill
probabl
sar
patient
throat
swab
specimen
use
rtpcr
cognat
serum
sampl
use
wb
assay
tn
singleserum
group
posit
rate
rtpcr
wb
measur
specimen
collect
acut
stage
day
ill
onset
posit
rate
rtpcr
wb
respect
convalesc
stage
day
ill
onset
pairedsera
group
posit
rate
rtpcr
wb
respect
overal
posit
rate
rtpcr
wb
combin
rtpcr
wb
result
laboratori
confirm
rate
probabl
sar
patient
increas
throat
swab
use
rtpcr
assay
wb
assay
use
recombin
protein
antigen
develop
detect
sarscovspecif
antibodi
evalu
whether
wb
could
use
sensit
specif
measur
compar
ifa
shown
tabl
recombinantproteinbas
wb
analysi
correl
well
wholevirusbas
ifa
find
indic
recombin
protein
n
may
use
antigen
detect
specif
antibodi
sarscov
moreov
larg
amount
recombin
protein
easili
obtain
e
coli
system
offer
sever
advantag
antigen
prepar
virusinfect
cell
decreas
risk
infect
eas
perform
assay
standard
shown
tabl
nrelat
antigen
show
princip
antigen
sarscov
rtpcrposit
patient
antigen
contribut
overal
posit
rate
data
relat
krokhin
et
al
conduct
wb
assay
use
convalesc
sera
sar
patient
detect
protein
supernat
cell
contain
sarscov
identifi
predomin
protein
n
minut
quantiti
protein
howev
could
detect
antibodi
e
protein
sar
patient
antibodi
protein
find
correl
result
obtain
elia
et
ai
report
antibodi
protein
canin
coronaviru
consist
detect
seroposit
dog
term
reactiv
differ
immunoglobulin
class
found
specif
iga
antibodi
alreadi
exist
day
ill
onset
case
howev
time
igm
antibodi
could
detect
patient
fig
weak
signal
igm
might
result
characterist
igm
sinc
affin
igm
antigen
rel
low
compar
igg
iga
therefor
detect
sensit
igm
sarscov
protein
limit
human
respiratori
tract
propos
major
site
sarscov
infect
human
total
cover
mucos
surfac
cellular
immun
respons
result
mucosat
infect
intracellular
pathogen
also
secretori
iga
produc
function
anoth
import
defens
mechan
invas
deeper
tissu
pathogen
therefor
synthesi
specif
iga
antibodi
earli
stage
sarscov
infect
reason
phenomenon
also
observ
studi
relat
coronavirus
exampl
loa
et
al
report
specif
iga
antibodi
turkey
coronaviru
initi
detect
serum
week
oral
inocul
gradual
increas
reach
peak
week
final
declin
week
furthermor
note
three
class
immunoglobulin
react
n
antigen
antibodi
respons
igm
antigen
much
lower
iga
igg
whether
phenomenon
signific
immunolog
role
iga
igg
igm
sar
patient
requir
detail
investig
tabl
illustr
rtpcr
sensit
wb
acut
phase
sarscov
infect
howev
wb
sensit
rtpcr
sera
collect
convalesc
phase
ill
gener
combin
use
rtpcr
wb
rais
posit
rate
probabl
sar
patient
taken
togeth
data
indic
use
recombin
proteinbas
wb
along
rtpcr
increas
rate
confirm
suspect
sar
patient
